COMPANY NAME	REVENUES 12 Months Ending Q2 2026	MARKET SHARE 12 Months Q2 2026	MARKET SHARE MRQ Q2 2026	MARKET SHARE A Quarter Before Q1 2026
Precipio inc	25.83	0.81%	0.81 %	0.81 %
Guardant Health Inc	1,080.22	33.80%	38.55%	36.19%
Myriad Genetics Inc	828.00	25.91%	21.95%	23.95%
Neogenomics Inc	745.91	23.34%	21.39%	22.96%
Veracyte Inc	516.18	16.15%	17.30%	16.10%

PRPO's Market share relative to its competitors, as of Q2 2026 within the Healthcare Sector

As of Q2 2026

COMPANY NAME	MARKET SHARE 12 Months Ending Q2 2026	MARKET SHARE 12 Months Ending Q1 2026	MARKET SHARE MRQ Q2 2026	MARKET SHARE Q1 2026
Precipio inc	1.05%	1.04%	1.03 %	1.05 %
Guardant Health Inc	44.09%	42.34%	49.04%	46.98%
Myriad Genetics Inc	33.79%	35.51%	27.92%	31.08%
Veracyte Inc	21.07%	21.11%	22.01%	20.89%

Note: Market share is calculated based on total revenue. To get a more accurate picture of Precipio inc's market divisions, geographic dispersion, segments, products, and services, visit Precipio inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.